Literature DB >> 299893

Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.

M F Woodruff, N L Warner.   

Abstract

The effect of systemic or local injection of Corynebacterium parvum at the tumor site on the growth of various murine tumors was studied in intact and congenitally athymic BALB/c mice. Systemic injection of C. parvum usually had a marked antitumor effect in both types of mouse. Two lymphomas, which regressed spontaneously in untreated intact mice but not in athymic mice, grew progressively in intact mice given systemic C. parvum, though their growth was inhibited in similarly treated athymic mice. Local injection into the site of the tumor markedly inhibited tumor growth in intact mice but was without effect in athymic mice. C. parvum was believed to exert its antitumor effects by two different mechanisms, only one of which was T-cell dependent. The mechanism not dependent on T-cells was particularly activated by systemic C. parvum injection.

Entities:  

Mesh:

Year:  1977        PMID: 299893     DOI: 10.1093/jnci/58.1.11

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  Local microwave hyperthermia (43 degrees C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats.

Authors:  M Janiak; W Hryniewicz; J Jeljaszewicz; G Pulverer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

2.  Comparison of natural killer cells induced by Kunjin virus and Corynebacterium parvum with those occurring naturally in nude mice.

Authors:  R I Macfarlan; R Ceredig; D O White
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Synergistic anti-suppressor effect of mini cells prepared from Salmonella typhimurium and mitomycin C in EL 4-bearing mice.

Authors:  S Kurashige; Y Akuzawa; S Mitsuhashi
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

5.  Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.

Authors:  E A Murano; C S Cummins
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.

Authors:  I Sugawara; K C Lee; M Wong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

8.  Antimicrobial properties of Kupffer cells.

Authors:  G A Filice
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

9.  Enhancing effects of mini-cells prepared from Salmonella typhimurium on anti-tumor immunity in sarcoma 180-bearing mice.

Authors:  S Kurashige; S Mitsuhashi
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

10.  Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. I. Analysis of natural immune defense.

Authors:  M Zöller
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.